Related Experiment Video
Updated: Dec 17, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The Multiple Roles of the IAP Super-family in cancer
Swati Kumar1, Ciaran Fairmichael1, Daniel B Longley1
1Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, United Kingdom.
Abstract:
The Inhibitor of Apoptosis proteins (IAPs) are a family of proteins that are mainly known for their anti-apoptotic activity and ability to directly bind and inhibit caspases. Recent research has however revealed that they have extensive roles in governing numerous other cellular processes. IAPs are known to modulate ubiquitin (Ub)-dependent signaling pathways through their E3 ligase activity and influence activation of nuclear factor κB (NF-κB). In this review, we discuss the involvement of IAPs in individual hallmarks of cancer and the current status of therapies targeting these critical proteins.
Insights
Inhibitor of Apoptosis proteins (IAPs) regulate cell death and signaling pathways. This review explores their roles in cancer hallmarks and emerging targeted therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Inhibitor of Apoptosis proteins (IAPs) are recognized for their anti-apoptotic functions and caspase inhibition.
- Emerging evidence highlights IAPs' broader roles in cellular processes beyond apoptosis.
- IAPs modulate ubiquitin-dependent signaling and nuclear factor κB (NF-κB) activation via E3 ligase activity.
Purpose of the Study:
- To review the multifaceted roles of IAPs in cancer.
- To discuss the involvement of IAPs in the hallmarks of cancer.
- To summarize the current landscape of therapies targeting IAPs.
Main Methods:
- Literature review of IAP functions in cancer.
- Analysis of IAP involvement in cancer hallmarks.
- Overview of current therapeutic strategies targeting IAPs.
Main Results:
- IAPs are implicated in multiple cancer hallmarks, including proliferation, survival, and immune evasion.
- Dysregulation of IAP pathways contributes to cancer development and progression.
- Targeting IAPs presents a promising therapeutic avenue in oncology.
Conclusions:
- IAPs are critical regulators with significant implications in cancer.
- Therapeutic strategies targeting IAPs are under active investigation.
- Further research into IAP biology may uncover novel cancer treatments.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...